Background Recent guidelines have suggested that testing young dyspeptic patients for Helicobacter pylori infection will produce more appropriate referrals for endoscopic investigation. Our aim was to describe how awareness of patient H. pylori status changes the practice of general practitioners (GPs) who do not currently use H. pylori testing and/or eradication in their management of dyspepsia. We studied a 5 per cent systematic sample (n = 177), stratified by health authority, of GPs in the North West region of England.
Introduction
It has been suggested that an awareness of the Helicobacter pylori status of patients presenting with symptoms of persistent but uncomplicated dyspepsia might result in general practitioners (GPs) making more appropriate referrals for endoscopic investigation. 1 -2 The magnitude of this benefit will depend upon both the prevalence of H. pylori infection within the dyspeptic population and how GPs change their management in response to knowledge of patient H. pylori status. We describe how awareness of H. pylori status changes the practice of GPs who do not currently use H. pylori testing and/or eradication strategies in the management of dyspepsia.
Methods
A short questionnaire with multiple choice investigative and therapeutic options was constructed around brief vignettes reflecting clinical dilemmas faced by GPs in the management of dyspepsia. The questionnaire was pre-tested sequentially on two small convenience samples of GPs.
The final study population of 177 participants comprised a 5 per cent systematic sample, stratified by health authority, of GPs registered in the North West in 1995. Questionnaires were distributed by post; non-respondents were sent reminders and then contacted by telephone.
Results
One hundred and forty (79 per cent) GPs responded to the survey. Twenty-five indicated that they already used H. pylori testing and/or eradication strategies for the management of dyspepsia (Table 1) , and these GPs were excluded from further analyses. Tables 2 and 3 show how the remaining 115 GPs who did not use H. pylori testing would have changed their management when faced with a patient whose H. pylori status was known. When the patient was known to be H. pylori positive, five (4 per 
How may knowledge of H. pylori status change endoscopy referral rates?
Thirty-three (29 per cent) of the 115 GPs would refer for endoscopy the young dyspeptic patient whose H. pylori status was unknown. When the vignette revealed the patient's H. pylori status, 37 (32 per cent) responded that they would then refer the H. pylori positive patient for endoscopy and 25 (22 per cent) the H. pylori negative patient.
Modelling the impact of H. pylori testing
The results from this survey can be used to explore the possible impact that the introduction of widespread testing for H. pylori infection in primary care might have on subsequent endoscopy workload.
If the proportion of patients (y) referred for endoscopy were to reflect the pooled preferences of the GPs in this survey, then the relationship with prevalence can be described as where x is the prevalence of H. pylori infection in the population tested (Fig. 1) . The application of this formula suggests that widespread testing for H. pylori infection will increase endoscopy referral rates from the baseline rate (29 per cent) only if the prevalence of infection among the young dyspeptic population exceeds 67 per cent.
Discussion
This survey has demonstrated that GP knowledge of patient H. pylori status may substantially change the choice of drugs used to treat dyspepsia in primary care. Over three-quarters of respondents would choose eradication therapy rather than ulcer healing drugs if they knew a patient was positive for H. pylori infection. The results also suggest that that the systematic introduction of H. pylori testing in this population of GPs who at present do not use such investigations might reduce the baseline endoscopy referral rate of 29 per cent were the prevalence of infection among dyspeptic patients found to be less than 67 per cent.
The use of clinical vignettes as a means of assessing selfreported practice, however, requires cautious interpretation. It is possible that GPs respond in a manner which reflects that which is perceived to be optimal rather than what is routinely achievable in everyday practice. The high response rate to the questionnaire suggests a substantial level of interest in this topic among GPs at present, and we believe the conclusions drawn are valid for this population. Access to endoscopy services, serology testing, and even the prevalence of H. pylori infection, however, may vary nationally. The change in endoscopy workload predicted by the answers to this questionnaire has resulted from an inconsistent set of clinical responses to knowledge of patient H. pylori status. Some GPs would refer only the H. pylori positive patients for endoscopy, others only negative patients, and a small number both positive and negative patients. This contrasts with recent dyspepsia management guidelines from the British Society of Gastroenterology,' which recommend that patients under the age of 45 years who test positive for H. pylori should be referred for endoscopy and those who test negative managed symptomatically without further investigation. However, were such a policy to be uniformly adopted in our study population, then this would have had substantial implications for secondary care workload; referral rates would have increased beyond baseline once H. pylori prevalence exceeds 29 per cent Such a strategy also presumes that no negative patient will ever require or request an endoscopic examination.
A substantial number of GPs stated that they would refer patients for endoscopy and prescribe a concomitant course of acid suppression therapy. This may compromise the efficacy of the endoscopic examination; induced gastric acid suppression may mask peptic ulceration by enhancing mucosal healing, and thus 'false negative' endoscopic examinations may result. However, as the average waiting time for open access endoscopy reported by respondents in this survey was seven weeks (data not presented), a dilemma exists between the need to control patient symptoms and maximize the yield of planned diagnostic interventions.
The appropriateness of H. pylori testing in the management of young patients with uninvestigated dyspepsia remains unclear. These results indicate a widespread willingness among GPs to eradicate H. pylori infection on the basis of a positive serology test result with no further investigation. Such an approach has recently been endorsed by the European Helicobacter pylori Study Group. 3 The utility of eradication therapy in the management of seropositive uninvestigated dyspepsia, however, is unproven, as less than one-quarter of patients are likely to have underlying ulcer disease, and the symptomatic benefits of treating non-ulcer dyspepsia in this way are equivocal. It is probable therefore that a substantial proportion of these patients will re-present symptomatically and may, in the longer term, require endoscopic investigation to establish a definitive diagnosis. Until such a strategy has been evaluated in appropriate prospective randomized controlled trials, advocates of H. pylori testing as a means to reduce endoscopy referrals should be cautious about its potential impact on service workload.
